Some visit links earn us a commission.
Quick verdict
Embla is the better pick for most patients on overall scoring. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
That said, Zealthy wins on specific dimensions. A bundled cash-pay option that folds the membership and compounded semaglutide into one $297/mo price, plus an insurance-coordination route for branded GLP-1s. The all-in bundle is mid-pack; the medication-only teaser ($151/mo on a quarterly supply) excludes the membership and is not the ongoing all-in.
Side-by-side
| Embla | Zealthy | |
|---|---|---|
| Starts from | $249/mo (+ med separate) | $297/mo (incl. medication) |
| Monthly cost gap | Embla is $48/mo cheaper than Zealthy | |
| Lock-in | 12-mo lock-in | Month-to-month |
| Time to prescription | 7 days | 2 days |
| Consultation type | Live | Online |
| Affiliate network | Impact | - |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Embla | Zealthy | |
|---|---|---|
| Pricing transparency | 4/10 | 4/10 |
| Cancellation terms | 7/10 | 4/10 |
| Onboarding experience | 6/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9.2/10 | 6.4/10 |
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on cancellation terms, member reviews and runs $48/mo cheaper than Zealthy at the entry tier ($249 vs $297). Over a year that's $576 you keep. The caveat: Buyers who only want the script and find coaching content patronizing.
When to choose Zealthy
Best for bundled cash-pay plus insurance help
Cash-pay patients who want the membership and compounded medication billed as one number, or who want help coordinating insurance for a branded GLP-1.
Zealthy wins on onboarding experience on the dimensional scoring. The caveat: Patients who want the lowest possible compounded price, or who do not want a recurring membership. Note also: Regulatory caution: the FDA issued a warning letter to FitRX, LLC (which operates Zealthy) on September 9, 2025 over false or misleading compounded-semaglutide marketing claims.
If cost is your main filter
Embla is the cheaper monthly: $249 all-in vs $297 for Zealthy. That's $48 a month or $576a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $144 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Embla (12-mo lock-in) and Zealthy (month-to-month) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Zealthy's easier cancellation is the safer trial.
FAQ
Is Embla cheaper than Zealthy?
Can I switch from Embla to Zealthy mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
